Company news

Beihai Gofar Chuanshan Biological Co. Ltd. Class A (SSE:600538) news

Beihai Gofar Chuanshan Biological Co. Ltd. Class A news releases on 6ix. Latest, Sep 16, 2026: "Beihai Gofar Chuanshan Biological Co., Ltd."Announcement…

Beihai Gofar Chuanshan Biological Co. Ltd. Class A (SSE:600538) news

Press releases & updates

"Beihai Gofar Chuanshan Biological Co., Ltd."Announcement on Outline of the 2026 Semi-annual Performance Briefing

"Beihai Gofar Chuanshan Biological Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance Briefing

"Beihai Gofar Chuanshan Biological Co., Ltd."Announcement on Resolutions of the 4th Meeting of the 12th Board of Directors

"Beihai Gofar Chuanshan Biological Co., Ltd."Announcement on Change of Office Address

"Beihai Gofar Chuanshan Biological Co., Ltd."Announcement on Expected Loss in Semi-annual Performance for 2026

Announcement on Purchase of Minority Equity in Guangzhou Gaosheng Intelligent Manufacturing Technology Co., Ltd. and Related Party Transactions

Indicative Announcement on Completion of Judicial Auction Transfer of Shares by the Former Controlling Shareholder and Actual Controller, and the Resulting Change to No Controlling Shareholder and No Actual Controller

Announcement on Resolutions of the 1st Meeting of the 12th Board of Directors

Announcement on Election of Employee Representative Directors for the 12th Board of Directors

Announcement on Outline of the Performance Briefing for 2025 and Q1 2026

Report for Q1 2026

Indicative Announcement on the Result of Judicial Auction of Shares Held by Zhu Rongjuan, the Controlling Shareholder, and the Possible Change of the Company's Controlling Shareholder and Actual Controller

Announcement on Resolutions of the 23rd Meeting of the 11th Board of Directors

Indicative Announcement on Judicial Auction of Some Company Shares Held by the Largest Shareholder

Announcement on Beijing Xiangya Terminating the Cooperation Agreement with Suqian Imaging Center

Announcement on the Wholly-owned Subsidiary Koalson Biotech Obtaining High-tech Enterprise Certificate

Announcement on Reply to Letter of Inquiry from Shanghai Stock Exchange on Related Matters of Earnings Preannouncement

Announcement on Expected Loss in Performance for 2025

Announcement on Judicial Rotation Freeze of Partial Shares Held by Major Shareholders

Announcement on Resignation of Director and Election of Employee Representative Director

Indicative Announcement on the Completion of Judicial Auction and Transfer of Some Shares Held by Majority Shareholders and Their Persons Acting in Concert and Equity Change

Announcement on Changing Signatory Certified Public Accountant

Announcement on Resolutions of the 21st Meeting of the 11th Board of Directors

Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025

Announcement on the By-election of Non-independent Directors through Cumulative Voting at the Shareholders’ Meeting

Announcement on Resignation of Chairman Mr. Jiang Ye

Announcement on Amending the Articles of Association and Relevant Governance Systems

Announcement on Judicial Auction Results of Some Company Shares Held by the Largest Shareholder and Its Persons Acting in Concert

Announcement on Judicial Rotation Freeze and Marking of Some Shares Held by the Person Acting in Concert of the Major Shareholder

Announcement on Judicial Rotation Freeze of Partial Shares Held by Major Shareholders and Persons Acting in Concert

Report for Q3 2025

Indicative Announcement on Judicial Auction of Some Company Shares Held by the Largest Shareholder and Its Persons Acting in Concert

Announcement on Outline of the 2025 Semi-annual Performance Briefing

Announcement on Convening the 2025 Semi-annual Performance Briefing

Announcement on the Completion of the Share Increase Plan for the Chairman and Results of Share Increase

2025 Semi-annual Report

Announcement on Providing Guarantee for Holding Subsidiary

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025

Announcement on Expected Decrease in Semi-annual Performance for 2025

Announcement on the Provision of Online Voting Reminder Service for the General Meeting

Announcement on Resolutions of the 16th Meeting of the 11th Board of Directors

Announcement on Reply to Letter of Inquiry on Post Audit of 2024 Annual Report

Announcement on the Completion of Implementation of the Company's Directors' Share Increase Plan and Results

Announcement on Progress in Shareholding Increase by Chairman Jiang Ye and Extending of Shareholding Increase Plan

Announcement on Resignation of Independent Director

Announcement on Resolution of the 2024 Annual General Meeting

Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing

Report for Q1 2025

Announcement on Provision for Impairment of Goodwill

Indicative Announcement on Share Transfer through Auction by Person Acting in Concert with Major Shareholder and Equity Change Reaching 1%